← Back to Search

Transcranial Magnetic Stimulation for Spinal Cord Injury (uMEP Trial)

N/A
Recruiting
Led By Blair Dellenbach, MSOT
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and final training session (approximately 2.5 months)
Awards & highlights

uMEP Trial Summary

This trial is testing if transcranial magnetic stimulation can help improve movement in people with incomplete spinal cord injury.

Who is the study for?
This trial is for individuals with incomplete spinal cord injury who are over 6 months post-injury, medically stable, and not expecting medication changes for 3 months. They must have weak wrist extension but can still move their arm voluntarily. People with motoneuron injuries, cognitive impairments, seizures, metal in the skull, pregnancy or certain implants cannot join.Check my eligibility
What is being tested?
The study tests if training the brain-to-muscle pathway using a magnetic stimulator improves arm movement in those with spinal cord injuries. Participants will train their wrist extensor muscle response to this stimulation over 30 visits lasting about 1.5 hours each.See study design
What are the potential side effects?
Using transcranial magnetic stimulation may cause little to no discomfort; however specific side effects aren't detailed here. It's generally considered safe but could potentially trigger headaches or scalp sensations at the site of stimulation.

uMEP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and final training session (approximately 2.5 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and final training session (approximately 2.5 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in ability to move the arm as measured by the Action Research Arm Test (ARAT). Maximum score of 57 points
Change in ability to move the arm as measured by the Fugl-Meyer Assessment (FMA)
Change in fine motor ability and finger dexterity as measured by the Nine Hole Peg Test
+5 more

uMEP Trial Design

1Treatment groups
Experimental Treatment
Group I: MEP Wrist Extensor Up-ConditioningExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
933 Previous Clinical Trials
7,394,610 Total Patients Enrolled
Blair Dellenbach, MSOTPrincipal InvestigatorMedical University of South Carolina

Media Library

MEP Operant Up-conditioning of the Wrist Extensor Clinical Trial Eligibility Overview. Trial Name: NCT05321017 — N/A
Spinal Cord Injury Research Study Groups: MEP Wrist Extensor Up-Conditioning
Spinal Cord Injury Clinical Trial 2023: MEP Operant Up-conditioning of the Wrist Extensor Highlights & Side Effects. Trial Name: NCT05321017 — N/A
MEP Operant Up-conditioning of the Wrist Extensor 2023 Treatment Timeline for Medical Study. Trial Name: NCT05321017 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current participant count for this experiment?

"Verified, the clinical trial is currently recruiting. The investigation was published on December 10th 2021 and updated most recently on April 8th 2022. Five individuals will be admitted to a single research centre."

Answered by AI

Are investigators currently accepting participants for this trial?

"According to information posted on clinicaltrials.gov, this medical endeavour is currently searching for participants. This trial was initially made public on October 12th 2021 and underwent its most recent revision April 8th 2022."

Answered by AI
~0 spots leftby Jun 2024